Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Trial of Preoperative Short-Course Chemoradiotherapy Followed by Chemotherapy for Resectable Gastric Adenocarcinoma

NCT04523818 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04523818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04523818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Trial of Preoperative Short-Course Chemoradiotherapy Followed by Chemotherapy for Resectable Gastric Adenocarcinoma
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 11, 2020
Completion date
December 31, 2028
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage i gastric cancer ajcc v8, clinical stage iia gastric cancer ajcc v8, clinical stage iii gastric cancer ajcc v8, clinical stage iva gastric cancer ajcc v8, gastric adenocarcinoma, pathologic stage ib gastric cancer ajcc v8, pathologic stage ii gastric cancer ajcc v8, pathologic stage iia gastric cancer ajcc v8, pathologic stage iib gastric cancer ajcc v8, pathologic stage iii gastric cancer ajcc v8, pathologic stage iiia gastric cancer ajcc v8, pathologic stage iiib gastric cancer ajcc v8, pathologic stage iiic gastric cancer ajcc v8, postneoadjuvant therapy stage i gastric cancer ajcc v8, postneoadjuvant therapy stage ii gastric cancer ajcc v8, postneoadjuvant therapy stage iii gastric cancer ajcc v8